6th March 2026
Medilink Midlands Innovation Builder Strengthens Investment-Ready Health Innovation Pipeline
The Medilink Midlands Innovation Builder (MMIB), delivered by Medilink Midlands, is supporting ambitious health and medtech innovators to accelerate commercial viability and investor readiness across the Midlands.
Designed to move beyond early-stage concept support, the programme combines structured sprint-based delivery with expert-led guidance and direct engagement from investors, clinicians and sector specialists. Its focus is clear: building scalable, commercially credible businesses capable of attracting funding and strategic partnerships.
Through the Innovation Builder, participating companies develop:
- Defined commercial roadmaps and validation milestones
- Early identification and mitigation of technical and market risk
- Strategic partnerships that strengthen delivery and adoption pathways
- Robust, evidence-based investor propositions
- Access to a cross-sector network of clinicians, regulatory experts, commercial advisers and funders
By the end of the programme, innovators are equipped with the structure, data and market positioning required to engage investors and partners with greater confidence and clarity.
The Innovation Builder plays a key role in strengthening the regional pipeline of investable life sciences and medtech businesses, contributing to long-term ecosystem growth and improved healthcare outcomes.
Further information about the Medilink Midlands Innovation Builder can be found here.